Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). (Q33362781)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). |
scientific article |
Statements
1 reference
Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). (English)
1 reference
Michael Crump
1 reference
Tara Baetz
1 reference
Stephen Couban
1 reference
Andrew Belch
1 reference
Deborah Marcellus
1 reference
Kang Howson-Jan
1 reference
Kevin Imrie
1 reference
Robert Myers
1 reference
Grenfell Adams
1 reference
Keyue Ding
1 reference
Nancy Paul
1 reference
Lois Shepherd
1 reference
Jose Iglesias
1 reference
Ralph Meyer
1 reference
1 October 2004
1 reference
Identifiers
1 reference